Blueprint Medicines Corp logo

Blueprint Medicines Corp

1
1
NAS:BPMC (USA)  
$ 90.46 +0.13 (+0.14%) 01:00 PM EST
At Loss
P/B:
18.29
Volume:
113.60K
Avg Vol (2M):
697.77K
Trade In:
Volume:
113.60K
At Loss
Avg Vol (2M):
697.77K

Business Description

Description
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 1.56
Equity-to-Asset 0.26
Debt-to-Equity 1.51
Debt-to-EBITDA -6.24
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.89
Distress
Grey
Safe
Beneish M-Score -1.94
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 35.45
9-Day RSI 38.81
14-Day RSI 42.59
6-1 Month Momentum % -9.67
12-1 Month Momentum % 5.99

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.32
Quick Ratio 3.27
Cash Ratio 2.85
Days Inventory 539.72
Days Sales Outstanding 49.51
Days Payable 147.24

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.9
Shareholder Yield % -3.27

Financials (Next Earnings Date:2025-02-14 Est.)

BPMC's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BPMC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Blueprint Medicines Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 434.414
EPS (TTM) ($) -2.11
Beta 0.98
Volatility % 46.12
14-Day RSI 42.59
14-Day ATR ($) 3.540029
20-Day SMA ($) 94.25
12-1 Month Momentum % 5.99
52-Week Range ($) 72.24 - 121.9
Shares Outstanding (Mil) 63.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Blueprint Medicines Corp Filings

Filing Date Document Date Form
No Filing Data

Blueprint Medicines Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Blueprint Medicines Corp Frequently Asked Questions

What is Blueprint Medicines Corp(BPMC)'s stock price today?
The current price of BPMC is $90.46. The 52 week high of BPMC is $121.90 and 52 week low is $72.24.
When is next earnings date of Blueprint Medicines Corp(BPMC)?
The next earnings date of Blueprint Medicines Corp(BPMC) is 2025-02-14 Est..
Does Blueprint Medicines Corp(BPMC) pay dividends? If so, how much?
Blueprint Medicines Corp(BPMC) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1